VIM and chronic myelogenous leukemia, BCR-ABL1 positive: Kueper et al. (90) first determined that vimentin is the main target of CML in fibroblasts, and studies have shown that the accumulation of CML-vimentin can be found in the living skin fibroblasts of elderly donors.